This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The 3rd edition of Pharma Live Expo & Summit will be held from April 17 to 19, 2025, at the Bombay Exhibition Centre, Mumbai. Pharma Live Expo & Summit 2025 provides a unique platform for stakeholders across the pharmaceutical value chain to come together, exchange knowledge, and drive impactful advancements.
Looking ahead to 2025, were witnessing an industry in transformation. Product packaging has undergone major changes and now focuses on building sustainable capabilities to avoid dependence on eco-friendly materials. Meanwhile, companies are exploring eco-friendly solutions like energy-efficient refrigerants and sustainable packaging.
LOG Pharma Primary Packaging is set to present its new barrier eco line at Pharmapack Europe 2025. LOGs barrier packaging solutions are designed to prolong shelf life and protect innovative and generic drugs from the exposure to moisture and/or oxygen, the company explained on its website.
By Sara M Keup In reviewing some new 2025 pharmacy rules/laws a couple interesting changes caught this bloggers attention: As of December 30, 2024, Missouri has rolled out new rules related to prescription drug delivery requirements. Massachusetts will begin enforcement against non-licensed pharmacy dispensing beginning on May 1, 2025.
Pharmaceutical Technology sat down with Stefan Verheyden, Global Vice President Sales Pharma & Biopharma Solutions Injectables at Gerresheimer, to talk about the primary and secondary packaging solutions Gerresheimer and Bormioli Pharma will be showcasing at Pharmapack Europe 2025 in Paris, France from January 2223.
Pharmaceutical Technology spoke with Peter Belden, president of Tjoapack US, ahead of DCAT Week 2025 to discuss recent innovations in bio/pharmaceutical packaging.
CPHI Europe, reportedly, the world’s largest pharmaceutical event, will return to Messe Frankfurt from October 28-30, 2025. The event will gather the entire supply chain, including ingredients, finished dosages, machinery, bio, and packaging. CPHI events highlight industry trends, with analysts predicting growth in 2025.
Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock Ultra PAPER PACKAGING INNOVATION WINNER Mitsubishi Gas Chemical Company for new OXYCAPT Multilayer Plastic Vial PATIENT-CENTRIC DESIGN WINNER UCB Pharma for Bimzelx 160mg 2ml autoinjectors product (..)
As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. From eco-friendly packaging to socially responsible campaigns, sustainability resonates with today’s consumers. Learn more about compliance tips at Pharma Marketing.
Your Roadmap to Category Management Success in 2025 priyanka.katke… Mon, 11/18/2024 - 17:57 Your Roadmap to Category Management Success in 20252025 will feel familiar, in some regards. To prepare for all eventualities, grab your copy of the GEP Spend Category Outlook Report 2025.
Jayakumar gave examples of common issues, such as packaging damage or consistency problems in ointments, stressing the importance of not dismissing seemingly minor complaints, as they could escalate into more significant quality issues.
January 15, 2025 : “Johnson & Johnsonannounced it has initiated the submission of an original New Drug Application with the U.S. It is placed into the bladder by a healthcare professional using a co-packaged urinary placement catheter in an outpatient setting in under five minutes and without the need for anesthesia.
According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging. The construction projects will be finalised from the end of 2025 through to 2029. Most of the investment will be focused on API capacity.
The introduction of Velocity Vials will contribute to the ongoing evolution of our offerings and services and will expand our portfolio of high-quality tubular glass packaging. Pharma tubing production is expected to begin in 2025. Manufacturing of Velocity Vials at SGD Pharma’s facility in Vemula, India, is expected to begin in 2024.
.” Harshit Shah, President of IPMMA, remarked, “Pharma Pro&Pack Expo 2024 has once again demonstrated its critical role in driving innovation and collaboration across the pharmaceutical processing and packaging sectors. ” Exhibitors and visitors shared positive feedback about the event’s success. .”
At its Le Trait site in Normandy, Sanofi added that it will devote €100 million for new capacity for biologics formulation, filling, device assembly and packaging. Sanofi shared that it plans to launch in 2025. Sanofi expects that 350 jobs will be created at the facility following this investment. The facility will be low-carbon.
The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and commercial drug products.
How GEP Helped a Pharma Company Save $2M With Sustainable Sourcing priyanka.katke Thu, 01/16/2025 - 16:02 Balancing sustainability goals with cost efficiency in your supply chain management is no small feat. Read this case study to learn how a global pharmaceutical leader fixed inefficiencies in a 25M packaging budget.
CPI confirmed that the centre will establish operations during 2024 and be finished in late 2025. This is a first-of-its-kind collaboration for the pharma industry. Partners include AstraZeneca, GSK, and the University of Strathclyde. The project will be jointly funded by the UK and Scottish Governments.
Over the years, we have continued to seek improvements to existing molecules to better meet patient needs – we have introduced novel heat-stable generic formulations, more convenient packaging options, and paediatric therapies.
package insert. by the 2024/2025 respiratory virus season,” the statement informs. A follow-up analysis of the primary endpoint was performed during FDA review, including cases that started before the primary analysis cut-off date but were not confirmed until afterward. The results were consistent with the primary analysis [VE 78.7
and Europe held manufacturers accountable for their environmental impact, leading to an increase in partnerships with tech companies focused on sustainable packaging and production solutions. What are the top 3 trends to watch out for in 2025,which could have a disproportionate impact on the globaland Indian life sciences landscape?
It is critical to understand the supply chain, plan your packaging, storage and distribution lanes, then test the entire process before patient shipments go live. Products are stored and packaged in a dedicated suite by a dedicated team,” explains MacNeir. The requirements When handling personalised medicines, time is of the essence.
Exchanging transaction information, verifying product identifiers, responding to regulator requests for transaction information, and gathering transaction information at the package level. For wholesalers, these exemptions are granted until August 27, 2025.
The Chinese government announced its ten-year 'Made in China 2025' strategic plan in 2015, which aimed to make the country a global leader in several high-tech industries. These industries unexpectedly also included biotech, which was not a particularly strong area for Chinese manufacturing, which is more recognised for generics production.
As the new law unfolds—and as state laws regarding ingredients and packaging, as well as laws regarding environmental claims continue to affect the cosmetics and personal care industries—the topics covered at the conference have never been more relevant.
While the FDA sent Lilly a complete response letter detailing issues pertaining to the proposed manufacturing of mirikizumab, the regulator raised no concerns about the clinical data package or label for the medicine. The recent setback dents mirikizumab’s chances to be the first among the IL-23 inhibitors to launch in the US for UC.
It, too, announced plans to invest $500 million in a new facility in Africa for the production, fill/finish and packaging of mRNA vaccines. The company also presented results in November for their AstraZeneca-partnered mRNA candidate for heart failure. Some of that funding will go towards expanding the mRNA team to 400 staff.
From 31 January 2025, new and ongoing clinical trials in the EU must be conducted in compliance with the CTR. Authorisation of the clinical trial, may, however, be obtained later. The proposed revisions will form the basis of the future regulation of the pharmaceutical industry in the EU and are anticipated for publication in mid-March.
Technology was used to handle costly administration issues. The Resulting Package By 2020, it was clear that One Medical was hitting a positive note with the market, and so it went public. If in-person, when patients arrived at the clinic, they would only see a receptionist and a doctor. Prime and, of course, One Medical members.
The leading IOC in the new electricity market is BP, which, through its subsidiary Lightsource bp, is projecting the sale of 25 GW of green electricity projects by 2025, but with only 4 GW of associated storage, or just 3% of the IEA’s projected 2025 demand of 148 GW. This includes trading and microgrid packages.
Expanding PEPFAR’s procurement goals There are currently about 600 manufacturers producing packaged medicines in Africa , with 80 percent of those producers concentrated in just eight countries. By 2025, PEPFAR aims to procure 15 million HIV tests from African manufacturers. But PEPFAR is looking to change how it does business.
The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 billion by 2033, according to a study published by Towards Packaging. Specifically, the “high quality of biodegradable and recyclable packaging materials” are driving the market.
… The White House is pitching an added benefit to the recent drug-pricing reform package: lower cancer death rates , STAT explains. A A new analysis by the Council of Economic Advisers focused on a provision that caps Medicare out-of-pocket costs for pharmacy drugs at $2,000 a year, starting in 2025.
These new results reinforce our differentiating data package for PDC*lung01. After the completion of the current clinical study with PDC*lung01 (PDC-LUNG-101), we plan to conduct a randomized, open-label phase 2 clinical trial with PDC*lung in the B2 cohort setting (2025 to 2028).
The requirement for Part D sponsors to provide translated materials in any non-English language that is the primary language of at least five percent of individuals in a Plan Benefit Package (PBP) service area is a step in the right direction towards addressing health disparities and promoting equity in health care access.
The requirement for Part D sponsors to provide translated materials in any non-English language that is the primary language of at least five percent of individuals in a Plan Benefit Package (PBP) service area is a step in the right direction towards addressing health disparities and promoting equity in health care access.
The agreement stipulates that certain conditions must be met in the labelling and packaging of these medicinal products. The following new measures are set to be introduced on 1 January 2025. After this date: Under the framework, medicines can have the same packaging and labelling across the UK.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content